{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T21:12:57Z","timestamp":1785445977775,"version":"3.56.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019624","name":"University Hospital Hradec Kralove","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032164","name":"Univerzita Obrany","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032164","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.arr.2026.103187","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T06:04:17Z","timestamp":1779689057000},"page":"103187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Revisiting butyrylcholinesterase in Alzheimer's disease: A hub linking cholinergic, metabolic and affective pathways"],"prefix":"10.1016","volume":"119","author":[{"given":"Barbora","family":"Svobodova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Soukup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6977-7596","authenticated-orcid":false,"given":"Jan","family":"Korabecny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2026.103187_bib1","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1021\/acschemneuro.5c00683","article-title":"Effects of ghrelin hormone on Alzheimer\u2019s and Parkinson\u2019s disease: a systematic review of the existing literature","volume":"16","author":"Abdulazeez","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2026.103187_bib2","first-page":"239","article-title":"Design and synthesis of 4-arylazo pyrazole carboxamides as Dual AChE\/BChE inhibitors: kinetic and in silico evaluation","volume":"19","author":"Akocak","year":"2026","journal-title":"Pharm. (Basel)"},{"key":"10.1016\/j.arr.2026.103187_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.arr.2026.103187_bib4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nchembio.1858","article-title":"Catalytic in vivo protein knockdown by small-molecule PROTACs","volume":"11","author":"Bondeson","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.arr.2026.103187_bib5","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1007\/s10072-022-06068-x","article-title":"Anxiety and depression in Alzheimer\u2019s disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline","volume":"43","author":"Botto","year":"2022","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.arr.2026.103187_bib6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cbi.2016.02.013","article-title":"Physiological roles for butyrylcholinesterase: A BChE-ghrelin axis","volume":"259","author":"Brimijoin","year":"2016","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.arr.2026.103187_bib7","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s44220-025-00416-4","article-title":"Anxious-depressive symptoms and sleep disturbances across the Alzheimer disease spectrum","volume":"3","author":"Chai","year":"2025","journal-title":"Nat. Ment. Health"},{"key":"10.1016\/j.arr.2026.103187_bib8","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1073\/pnas.1421536112","article-title":"Plasma butyrylcholinesterase regulates ghrelin to control aggression","volume":"112","author":"Chen","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2026.103187_bib9","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1017\/S003329172200397X","article-title":"Antidepressant medications in dementia: evidence and potential mechanisms of treatment-resistance","volume":"53","author":"Costello","year":"2023","journal-title":"Psychol. Med"},{"key":"10.1016\/j.arr.2026.103187_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1231361","article-title":"Role of fronto-limbic circuit in neuropsychiatric symptoms of dementia: clinical evidence from an exploratory study","volume":"15","author":"Cotta Ramusino","year":"2024","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.arr.2026.103187_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/156720510790274455","article-title":"Effects of cholinesterase inhibitors on the activities and protein levels of cholinesterases in the cerebrospinal fluid of patients with Alzheimer\u2019s disease: a review of recent clinical studies","volume":"7","author":"Darreh-Shori","year":"2010","journal-title":"Curr. Alzheimer Res"},{"key":"10.1016\/j.arr.2026.103187_bib12","doi-asserted-by":"crossref","first-page":"37299","DOI":"10.1021\/acsomega.4c05089","article-title":"Repurposing Duloxetine as a Potent Butyrylcholinesterase Inhibitor: Potential Cholinergic Enhancing Benefits for Elderly Individuals with Depression and Cognitive Impairment","volume":"9","author":"Darreh-Shori","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.arr.2026.103187_bib13","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S1474-4422(09)70298-4","article-title":"Alzheimer\u2019s disease: a global challenge for the 21st century","volume":"8","author":"Dartigues","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2026.103187_bib14","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2174\/1567205013666160404120542","article-title":"Butyrylcholinesterase as a diagnostic and therapeutic target for Alzheimer\u2019s disease","volume":"13","author":"Darvesh","year":"2016","journal-title":"Curr. Alzheimer Res"},{"key":"10.1016\/j.arr.2026.103187_bib15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrn1035","article-title":"Neurobiology of butyrylcholinesterase","volume":"4","author":"Darvesh","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2026.103187_bib16","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3233\/JAD-160373","article-title":"Butyrylcholinesterase K and apolipoprotein e-\u025b4 reduce the age of onset of Alzheimer\u2019s disease, accelerate cognitive decline, and modulate donepezil response in mild cognitively impaired subjects","volume":"54","author":"De Beaumont","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2026.103187_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101552","article-title":"Characterization of a novel BCHE \u201csilent\u201d allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium","volume":"9","author":"Delacour","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2026.103187_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.niox.2022.12.001","article-title":"Ghrelin activates the mesolimbic dopamine system via nitric oxide associated mechanisms in the ventral tegmental area","volume":"131","author":"Engel","year":"2023","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.arr.2026.103187_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108748","article-title":"Dual inhibition of butyrylcholinesterase and p38\u03b1 mitogen-activated protein kinase: A new approach for the treatment of Alzheimer\u2019s disease","volume":"264","author":"Ferjan\u010di\u010d Benetik","year":"2024","journal-title":"Pharmacol. & Ther."},{"key":"10.1016\/j.arr.2026.103187_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000487358","article-title":"Rivastigmine Improves Appetite by Increasing the Plasma Acyl\/Des-Acyl Ghrelin Ratio and Cortisol in Alzheimer Disease","volume":"8","author":"Furiya","year":"2018","journal-title":"Dement Geriatr. Cogn. Dis. Extra"},{"key":"10.1016\/j.arr.2026.103187_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110680","article-title":"Butyrylcholinesterase and lipid metabolism: Possible dual role in metabolic disorders","volume":"383","author":"Furtado-Alle","year":"2023","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.arr.2026.103187_bib22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1210\/endrev\/bnad033","article-title":"Appetite- and Weight-Regulating Neuroendocrine Circuitry in Hypothalamic Obesity","volume":"45","author":"Gan","year":"2024","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.arr.2026.103187_bib23","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.tem.2024.07.002","article-title":"Ghrelin","volume":"35","author":"Garcia-Rendueles","year":"2024","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.arr.2026.103187_bib24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.phrs.2003.11.017","article-title":"Cholinesterase inhibitors: new roles and therapeutic alternatives","volume":"50","author":"Giacobini","year":"2004","journal-title":"Pharm. Res"},{"key":"10.1016\/j.arr.2026.103187_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1079\/BJN20061787","article-title":"Ghrelin: a hormone regulating food intake and energy homeostasis","volume":"96","author":"Gil-Campos","year":"2006","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.arr.2026.103187_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.941467","article-title":"Altered levels of variant cholinesterase transcripts contribute to the imbalanced cholinergic signaling in Alzheimer\u2019s and Parkinson\u2019s disease","volume":"15","author":"Gok","year":"2022","journal-title":"Front Mol. Neurosci."},{"key":"10.1016\/j.arr.2026.103187_bib27","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/jnc.15833","article-title":"Butyrylcholinesterase in lipid metabolism: A new outlook","volume":"168","author":"Gok","year":"2024","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2026.103187_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13195-021-00781-z","article-title":"Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer\u2019s disease","volume":"13","author":"Grau-Rivera","year":"2021","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.arr.2026.103187_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2025.1625318","article-title":"New views on physiological functions and regulation of butyrylcholinesterase and potential therapeutic interventions","volume":"12","author":"Hajimohammadi","year":"2025","journal-title":"Front Mol. Biosci."},{"key":"10.1016\/j.arr.2026.103187_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000366198","article-title":"Effect of rivastigmine or memantine add-on therapy is affected by butyrylcholinesterase genotype in patients with probable Alzheimer\u2019s disease","volume":"73","author":"Han","year":"2015","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.arr.2026.103187_bib31","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1007\/s001250100033","article-title":"Butyrylcholinesterase K variant on chromosome 3 q is associated with Type II diabetes in white Caucasian subjects","volume":"44","author":"Hashim","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.arr.2026.103187_bib32","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1177\/02698811211030181","article-title":"Efficacy of antidepressant drugs in the treatment of depression in Alzheimer disease patients: a systematic review and network meta-analysis","volume":"35","author":"He","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.arr.2026.103187_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1592\/phco.20.1.1.34664","article-title":"Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer\u2019s disease","volume":"20","author":"Jann","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.arr.2026.103187_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnha.2024.100182","article-title":"Clinical and neuroimaging association between neuropsychiatric symptoms and nutritional status across the Alzheimer\u2019s disease continuum: a longitudinal cohort study","volume":"28","author":"Jiang","year":"2024","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.arr.2026.103187_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117995","article-title":"Discovery of new dual butyrylcholinesterase (BuChE) inhibitors and 5-HT7 receptor antagonists as compounds used to treat Alzheimer\u2019s disease symptoms","volume":"186","author":"Ku\u0142aga","year":"2025","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.arr.2026.103187_bib36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrd.2016.211","article-title":"Induced protein degradation: an emerging drug discovery paradigm","volume":"16","author":"Lai","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.arr.2026.103187_bib37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer\u2019s disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2026.103187_bib38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/FPC.0b013e3282f63f29","article-title":"Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer\u2019s disease","volume":"18","author":"Lane","year":"2008","journal-title":"Pharm. Genom."},{"key":"10.1016\/j.arr.2026.103187_bib39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2014.11.011","article-title":"Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses","volume":"148","author":"Lockridge","year":"2015","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.arr.2026.103187_bib40","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1021\/acs.chemrestox.6b00228","article-title":"Naturally Occurring Genetic Variants of Human Acetylcholinesterase and Butyrylcholinesterase and Their Potential Impact on the Risk of Toxicity from Cholinesterase Inhibitors","volume":"29","author":"Lockridge","year":"2016","journal-title":"Chem. Res Toxicol."},{"key":"10.1016\/j.arr.2026.103187_bib41","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.cmet.2008.03.006","article-title":"Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin","volume":"7","author":"L\u00f3pez","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.arr.2026.103187_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101891","article-title":"Apathy in Alzheimer\u2019s disease: A neurocircuitry based perspective","volume":"87","author":"Mehak","year":"2023","journal-title":"Ageing Res Rev."},{"key":"10.1016\/j.arr.2026.103187_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12603-021-1703-6","article-title":"Editorial: Anorexia of Ageing: Pathway to Frailty and Sarcopenia","volume":"26","author":"Merchant","year":"2022","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.arr.2026.103187_bib44","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3233\/ADR-230034","article-title":"Weight Change and Neuropsychiatric Symptoms in Alzheimer\u2019s Disease and Frontotemporal Dementia: Associations with Cognitive Decline","volume":"7","author":"Morrow","year":"2023","journal-title":"J. Alzheimers Dis. Rep."},{"key":"10.1016\/j.arr.2026.103187_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102843","article-title":"Gut-brain relationship in dementia and Alzheimer\u2019s disease: Impact on stress and immunity","volume":"111","author":"Mukherjee","year":"2025","journal-title":"Ageing Res Rev."},{"key":"10.1016\/j.arr.2026.103187_bib46","article-title":"A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer\u2019s disease","volume":"15","author":"Nordberg","year":"2013","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.arr.2026.103187_bib47","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1093\/brain\/awae069","article-title":"Cholinergic changes in Lewy body disease: implications for presentation, progression and subtypes","volume":"147","author":"Okkels","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.arr.2026.103187_bib48","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.3390\/cimb46070434","article-title":"Ghrelin\/GHSR System in Depressive Disorder: Pathologic Roles and Therapeutic Implications","volume":"46","author":"Pan","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.arr.2026.103187_bib49","article-title":"Genetic and functional dynamics of Butyrylcholinesterase in Alzheimer\u2019s disease: From mechanisms to clinical relevance","volume":"423","author":"Pre\u0161ern","year":"2025","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.arr.2026.103187_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104952","article-title":"Beyond appetite: Acylated ghrelin as a learning, memory and fear behavior-modulating hormone","volume":"143","author":"Reich","year":"2022","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.arr.2026.103187_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111012","article-title":"Interaction of exogenous acetylcholinesterase and butyrylcholinesterase with amyloid-\u03b2 plaques in human brain tissue","volume":"395","author":"Reid","year":"2024","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.arr.2026.103187_bib52","article-title":"Neuropsychiatric symptoms in Alzheimer\u2019s disease: Bridging mechanisms, management, and emerging innovations","author":"Rose","year":"2025","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.arr.2026.103187_bib53","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11357-024-01359-x","article-title":"Monoamine alterations in Alzheimer\u2019s disease and their implications in comorbid neuropsychiatric symptoms","volume":"47","author":"Saggu","year":"2025","journal-title":"Geroscience"},{"key":"10.1016\/j.arr.2026.103187_bib54","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.apsb.2025.02.030","article-title":"Discovery of novel butyrylcholinesterase inhibitors for treating Alzheimer\u2019s disease","volume":"15","author":"Sang","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.arr.2026.103187_bib55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s13539-012-0083-5","article-title":"Butyrylcholinesterase as a prognostic marker: a review of the literature","volume":"4","author":"Santarpia","year":"2013","journal-title":"J. Cachex-.-. Sarcopenia Muscle"},{"key":"10.1016\/j.arr.2026.103187_bib56","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2026.103187_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2023.114111","article-title":"How gut hormones shape reward: A systematic review of the role of ghrelin and GLP-1 in human fMRI","volume":"263","author":"Schulz","year":"2023","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.arr.2026.103187_bib58","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jconrel.2024.01.047","article-title":"Alzheimer\u2019s disease current therapies, novel drug delivery systems and future directions for better disease management","volume":"367","author":"Singh","year":"2024","journal-title":"J. Control Release"},{"key":"10.1016\/j.arr.2026.103187_bib59","unstructured":"Singh, R., Patel, P., 2026. Cholinesterase Inhibitors, in: StatPearls. StatPearls Publishing, Treasure Island (FL)."},{"key":"10.1016\/j.arr.2026.103187_bib60","unstructured":"Singh, R., Sadiq, N.M., 2025. Cholinesterase Inhibitors, in: StatPearls. StatPearls Publishing, Treasure Island (FL)."},{"key":"10.1016\/j.arr.2026.103187_bib61","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ymgme.2004.12.005","article-title":"Four new mutations in the BCHE gene of human butyrylcholinesterase in a Brazilian blood donor sample","volume":"84","author":"Souza","year":"2005","journal-title":"Mol. Genet Metab."},{"key":"10.1016\/j.arr.2026.103187_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116569","article-title":"New insights into butyrylcholinesterase: Pharmaceutical applications, selective inhibitors and multitarget-directed ligands","volume":"275","author":"Sun","year":"2024","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.arr.2026.103187_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102537","article-title":"Serotonin in depression and Alzheimer\u2019s disease: Focus on SSRI\u2019s beneficial effects","volume":"101","author":"Tahiri","year":"2024","journal-title":"Ageing Res Rev."},{"key":"10.1016\/j.arr.2026.103187_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2025.109259","article-title":"Machine learning-guided repurposing of FDA-approved quinolones as dual cholinesterase inhibitors: A multi-level docking, molecular dynamics, DFT, and SHAP-based analysis","volume":"143","author":"T\u00fcrke\u015f","year":"2026","journal-title":"J. Mol. Graph Model"},{"key":"10.1016\/j.arr.2026.103187_bib65","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/17568919.2026.2617608","article-title":"Isovanillin-derived bis-hydrazones as dual cholinesterase and carbonic anhydrase inhibitors: synthesis, enzymatic profiling, and computational insights from molecular docking and dynamics","volume":"18","author":"T\u00fcrke\u015f","year":"2026","journal-title":"Future Med Chem."},{"key":"10.1016\/j.arr.2026.103187_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.31274","article-title":"New paradigms in the study of the cholinergic system and metabolic diseases: Acetyl-and-butyrylcholinesterase","volume":"239","author":"Villeda-Gonz\u00e1lez","year":"2024","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.arr.2026.103187_bib67","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/med.21745","article-title":"Structure and therapeutic uses of butyrylcholinesterase: Application in detoxification, Alzheimer\u2019s disease, and fat metabolism","volume":"41","author":"Xing","year":"2021","journal-title":"Med Res Rev."},{"key":"10.1016\/j.arr.2026.103187_bib68","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.cmet.2018.02.008","article-title":"The Homeostatic Force of Ghrelin","volume":"27","author":"Yanagi","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.arr.2026.103187_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2025.120594","article-title":"Psychiatric symptoms and alzheimer\u2019s disease: Depression-anxiety comorbidity effects and their neurobiological mediating mechanisms","volume":"394","author":"Yang","year":"2026","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.arr.2026.103187_bib70","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00415-024-12800-8","article-title":"Dysregulation of energy metabolism in Alzheimer\u2019s disease","volume":"272","author":"Yuan","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2026.103187_bib71","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1517\/14740338.2014.914168","article-title":"Outcomes of Alzheimer\u2019s disease therapy with acetylcholinesterase inhibitors and memantine","volume":"13","author":"Zemek","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.arr.2026.103187_bib72","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41586-025-10018-w","article-title":"Biofluid biomarkers in Alzheimer\u2019s disease and other neurodegenerative dementias","volume":"650","author":"Zetterberg","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.arr.2026.103187_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1487875","article-title":"The neural basis of neuropsychiatric symptoms in Alzheimer\u2019s disease","volume":"16","author":"Zhang","year":"2024","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.arr.2026.103187_bib74","doi-asserted-by":"crossref","first-page":"313","DOI":"10.14283\/jpad.2021.15","article-title":"The Epidemiology of Alzheimer\u2019s Disease Modifiable Risk Factors and Prevention","volume":"8","author":"Zhang","year":"2021","journal-title":"J. Prev. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.arr.2026.103187_bib75","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi6856","article-title":"Rare genetic variability in human drug target genes modulates drug response and can guide precision medicine","volume":"7","author":"Zhou","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.arr.2026.103187_bib76","first-page":"405","article-title":"Genetic Testing for BCHE Variants identifies patients at risk of prolonged neuromuscular blockade in response to succinylcholine","volume":"13","author":"Zhu","year":"2020","journal-title":"Pharmgenomics Pers. Med"}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726001790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726001790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:42:27Z","timestamp":1783057347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163726001790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":76,"alternative-id":["S1568163726001790"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2026.103187","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revisiting butyrylcholinesterase in Alzheimer's disease: A hub linking cholinergic, metabolic and affective pathways","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2026.103187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103187"}}